Cargando…

Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses

Preferable treatments for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) with brain metastasis are elusive. The study intended to estimate the relative efficacy and safety of systemic therapies. Clinical trials about therapies for EGFR-mutant, brain-metastatic NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Binghao, Wang, Yuekun, Wang, Yaning, Chen, Wenlin, Zhou, Lizhou, Liu, Peng Hao, Kong, Ziren, Dai, Congxin, Wang, Yu, Ma, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425486/ https://www.ncbi.nlm.nih.gov/pubmed/32669477 http://dx.doi.org/10.18632/aging.103455

Ejemplares similares

Comprehensive ability evaluation and trend analysis of patients with malignant intracranial tumors in the perisurgery period
por: Wang, Yaning, et al.
Publicado: (2021)

Pretreatment Geriatric Assessments of Elderly Patients with Glioma: Development and Implications
por: Wang, Yaning, et al.
Publicado: (2020)

Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation
por: Lei, Chuxiang, et al.
Publicado: (2021)

Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
por: Zhao, Binghao, et al.
Publicado: (2022)

Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis
por: Zhao, Binghao, et al.
Publicado: (2021)

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021)

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021)

Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials
por: Chen, Wenlin, et al.
Publicado: (2021)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma
por: Zhao, Binghao, et al.
Publicado: (2023)

(18)F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
por: Kong, Ziren, et al.
Publicado: (2019)

Therapeutic options for advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer: a Bayesian network secondary analysis
por: Zeng, Xinmin, et al.
Publicado: (2020)

Palliative care for patients with glioma: A recent scientometric analysis of the Web of Science in 2022
por: Xiao, Zhiyuan, et al.
Publicado: (2022)

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
por: Zhao, Binghao, et al.
Publicado: (2022)

Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma
por: Wang, Zihao, et al.
Publicado: (2023)

Prognostic Value of Choline and Other Metabolites Measured Using (1)H-Magnetic Resonance Spectroscopy in Gliomas: A Meta-Analysis and Systemic Review
por: Shi, Yixin, et al.
Publicado: (2022)

(18)F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
por: Kong, Ziren, et al.
Publicado: (2019)

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials
por: Sun, Li, et al.
Publicado: (2021)

Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors
por: Wang, Yaning, et al.
Publicado: (2023)

Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
por: Kong, Ziren, et al.
Publicado: (2018)

Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
por: Ju, Jia-Shiuan, et al.
Publicado: (2023)

Superior efficacy of immunotherapy‐based combinations over monotherapy for EGFR‐mutant non‐small cell lung cancer acquired resistance to EGFR‐TKIs
por: Yang, Lu, et al.
Publicado: (2020)

Bayesian hierarchical negative binomial models for multivariable analyses with applications to human microbiome count data
por: Pendegraft, Amanda H., et al.
Publicado: (2019)

A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?
por: Han, Guang, et al.
Publicado: (2016)

Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
por: Deng, Guangchuan, et al.
Publicado: (2021)

Expression of EGFR in Pituitary Corticotroph Adenomas and Its Relationship With Tumor Behavior
por: Liu, Xiaohai, et al.
Publicado: (2019)

Tract-Based Bayesian Multivariate Analysis of Mild Traumatic Brain Injury
por: Liu, Yongkang, et al.
Publicado: (2014)

Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer
por: Wang, Haiyang, et al.
Publicado: (2018)

Role of (18)F-fluorodeoxyglucose (FDG) and (18)F-2-fluorodeoxy sorbitol (FDS) in autoimmune hypophysitis: a case report
por: Kong, Ziren, et al.
Publicado: (2020)

Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
por: Wen, Lei, et al.
Publicado: (2023)

Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis
por: Yan, Weiwei, et al.
Publicado: (2019)

Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency
por: Sun, Dantong, et al.
Publicado: (2023)

Correction to: Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
por: Deng, Guangchuan, et al.
Publicado: (2021)

Experimental Study of Almonertinib Crossing the Blood-Brain Barrier in EGFR-Mutant NSCLC Brain Metastasis and Spinal Cord Metastasis Models
por: Zhang, Yuhan, et al.
Publicado: (2021)

Effect of EGFR-TKIs combined with craniocerebral radiotherapy on the prognosis of EGFR-mutant lung adenocarcinoma patients with brain metastasis: A propensity-score matched analysis
por: Deng, Guangchuan, et al.
Publicado: (2023)

Prognostic Prediction Model for Glioblastoma: A Ferroptosis-Related Gene Prediction Model and Independent External Validation
por: Chen, Wenlin, et al.
Publicado: (2023)

Spatial Multivariate Trees for Big Data Bayesian Regression
por: Peruzzi, Michele, et al.
Publicado: (2022)

Bayesian multivariate genetic analysis improves translational insights
por: Urbut, Sarah M., et al.
Publicado: (2023)

Multivariate analyses in microbial ecology
por: Ramette, Alban
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_15kvvg9k2svcnfagaoakvr58ls